Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018408210> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2018408210 endingPage "S368" @default.
- W2018408210 startingPage "S361" @default.
- W2018408210 abstract "The efficacy and safety of bimatoprost, a member of a new class of pharmacological agents called prostamides, were compared with the efficacy and safety of timolol in patients with glaucoma or ocular hypertension. Pooled 6-month results from two ongoing, multicenter, randomized, double-masked, clinical trials were analyzed. Patients were randomized in a 2:2:1 ratio to treatment with bimatoprost 0.03% once a day ([QD] n = 474), bimatoprost 0.03% twice a day ([BID] n = 483), or timolol 0.5% BID (n = 241). Scheduled visits were at prestudy, baseline, week 2, week 6, month 3, and month 6. The primary outcome measure was in diurnal intraocular pressure ([IOP] 8 AM, 10 AM, 4 PM, 8 PM). Bimatoprost QD provided significantly greater mean IOP reductions from baseline than timolol at every time of the day and at each study visit (p </=.05). BID dosing of bimatoprost also provided significantly greater mean IOP reductions than timolol at most timepoints, but was not as effective as QD dosing. The IOP lowering provided by bimatoprost QD was sustained for 6 months. At month 6, the mean IOP reduction from baseline at 10 AM was 8.1 mm Hg (33%) with bimatoprost QD, 6.3 mm Hg (26%) with bimatoprost BID, and 5.6 mm Hg (23%) with timolol. Low target pressures were achieved by a significantly higher percentage of patients in the bimatoprost QD group than in the timolol group. At 10 AM (peak timolol effect) at month 6, IOP </= 17 mm Hg was achieved by 63.9% of bimatoprost QD patients, compared with 37.3% of timolol patients (p <.001). Bimatoprost was safe and well-tolerated, with few discontinuations due to adverse events. The most frequent side effect was trace-to-mild conjunctival hyperemia. Changes in iris pigmentation were reported in 1.1% of bimatoprost patients. There were no other significant findings in slit lamp examinations, ophthalmoscopy, visual acuity, or visual fields, and systemic safety parameters were also unaffected. Together these results indicate that bimatoprost QD is statistically and clinically superior to timolol in lowering IOP, and is safe and well-tolerated in patients with glaucoma or ocular hypertension." @default.
- W2018408210 created "2016-06-24" @default.
- W2018408210 creator A5082994754 @default.
- W2018408210 creator A5089416350 @default.
- W2018408210 date "2001-05-01" @default.
- W2018408210 modified "2023-10-17" @default.
- W2018408210 title "Six-Month Comparison of Bimatoprost Once-Daily and Twice-Daily with Timolol Twice-Daily in Patients with Elevated Intraocular Pressure" @default.
- W2018408210 cites W1490909919 @default.
- W2018408210 cites W1970065450 @default.
- W2018408210 cites W2004011839 @default.
- W2018408210 cites W2017429090 @default.
- W2018408210 cites W2026725758 @default.
- W2018408210 cites W2060184518 @default.
- W2018408210 cites W2060586423 @default.
- W2018408210 cites W2076260416 @default.
- W2018408210 cites W2093622776 @default.
- W2018408210 cites W2138342502 @default.
- W2018408210 cites W2323970533 @default.
- W2018408210 cites W2625521663 @default.
- W2018408210 doi "https://doi.org/10.1016/s0039-6257(01)00219-3" @default.
- W2018408210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11434939" @default.
- W2018408210 hasPublicationYear "2001" @default.
- W2018408210 type Work @default.
- W2018408210 sameAs 2018408210 @default.
- W2018408210 citedByCount "170" @default.
- W2018408210 countsByYear W20184082102012 @default.
- W2018408210 countsByYear W20184082102013 @default.
- W2018408210 countsByYear W20184082102014 @default.
- W2018408210 countsByYear W20184082102015 @default.
- W2018408210 countsByYear W20184082102016 @default.
- W2018408210 countsByYear W20184082102017 @default.
- W2018408210 countsByYear W20184082102018 @default.
- W2018408210 countsByYear W20184082102019 @default.
- W2018408210 countsByYear W20184082102020 @default.
- W2018408210 countsByYear W20184082102021 @default.
- W2018408210 countsByYear W20184082102022 @default.
- W2018408210 countsByYear W20184082102023 @default.
- W2018408210 crossrefType "journal-article" @default.
- W2018408210 hasAuthorship W2018408210A5082994754 @default.
- W2018408210 hasAuthorship W2018408210A5089416350 @default.
- W2018408210 hasConcept C118487528 @default.
- W2018408210 hasConcept C126322002 @default.
- W2018408210 hasConcept C168563851 @default.
- W2018408210 hasConcept C197934379 @default.
- W2018408210 hasConcept C2776521421 @default.
- W2018408210 hasConcept C2777288759 @default.
- W2018408210 hasConcept C2777336333 @default.
- W2018408210 hasConcept C2778073030 @default.
- W2018408210 hasConcept C2778527774 @default.
- W2018408210 hasConcept C2781092963 @default.
- W2018408210 hasConcept C42219234 @default.
- W2018408210 hasConcept C71924100 @default.
- W2018408210 hasConceptScore W2018408210C118487528 @default.
- W2018408210 hasConceptScore W2018408210C126322002 @default.
- W2018408210 hasConceptScore W2018408210C168563851 @default.
- W2018408210 hasConceptScore W2018408210C197934379 @default.
- W2018408210 hasConceptScore W2018408210C2776521421 @default.
- W2018408210 hasConceptScore W2018408210C2777288759 @default.
- W2018408210 hasConceptScore W2018408210C2777336333 @default.
- W2018408210 hasConceptScore W2018408210C2778073030 @default.
- W2018408210 hasConceptScore W2018408210C2778527774 @default.
- W2018408210 hasConceptScore W2018408210C2781092963 @default.
- W2018408210 hasConceptScore W2018408210C42219234 @default.
- W2018408210 hasConceptScore W2018408210C71924100 @default.
- W2018408210 hasLocation W20184082101 @default.
- W2018408210 hasLocation W20184082102 @default.
- W2018408210 hasOpenAccess W2018408210 @default.
- W2018408210 hasPrimaryLocation W20184082101 @default.
- W2018408210 hasRelatedWork W1830729863 @default.
- W2018408210 hasRelatedWork W1966103856 @default.
- W2018408210 hasRelatedWork W1970476186 @default.
- W2018408210 hasRelatedWork W1976486265 @default.
- W2018408210 hasRelatedWork W2010755453 @default.
- W2018408210 hasRelatedWork W2128476364 @default.
- W2018408210 hasRelatedWork W2169403898 @default.
- W2018408210 hasRelatedWork W2170698422 @default.
- W2018408210 hasRelatedWork W2612340917 @default.
- W2018408210 hasRelatedWork W3128736704 @default.
- W2018408210 hasVolume "45" @default.
- W2018408210 isParatext "false" @default.
- W2018408210 isRetracted "false" @default.
- W2018408210 magId "2018408210" @default.
- W2018408210 workType "article" @default.